SRX sierra rutile holdings limited
Add to My Watchlist 0.00% ! 17.5¢

Clinical Results

  1. aldiana
    4 Posts.
    clock Created with Sketch.
    16/05/17
    10:37
    Post #: 24711513
    No current holdings, but considering buying. Not sure how the market will assess a potential impairment loss in the FY16 accounts, resulting from the negative results of SARAH. When I look at the amount of capitalised intangibles for Clinical trials in the released half year results of $80m plus, I reckon a not insignificant amount is attributable to SARAH, hence a risk to the FY16 profit. Or am I missing the bigger picture? Any views & comments on that much appreciated.
    SRX Price at posting: $15.49 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
NEWS Askari sells Burracoppin Gold Project to Forrestania Resources
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.